Cargando…
The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy
Telomeropathies are rare disorders associated with impaired telomere length control mechanisms that frequently result from genetic mutations in the telomerase complex. Dyskeratosis congenita is a congenital progressive telomeropathy in which mutation in the telomerase RNA component (TERC) impairs te...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123533/ https://www.ncbi.nlm.nih.gov/pubmed/30210531 http://dx.doi.org/10.3389/fgene.2018.00345 |
_version_ | 1783352858194739200 |
---|---|
author | Jose, Shyam Sushama Tidu, Federico Burilova, Petra Kepak, Tomas Bendickova, Kamila Fric, Jan |
author_facet | Jose, Shyam Sushama Tidu, Federico Burilova, Petra Kepak, Tomas Bendickova, Kamila Fric, Jan |
author_sort | Jose, Shyam Sushama |
collection | PubMed |
description | Telomeropathies are rare disorders associated with impaired telomere length control mechanisms that frequently result from genetic mutations in the telomerase complex. Dyskeratosis congenita is a congenital progressive telomeropathy in which mutation in the telomerase RNA component (TERC) impairs telomere maintenance leading to accelerated cellular senescence and clinical outcomes resembling premature aging. The most severe clinical feature is perturbed hematopoiesis and bone-marrow failure, but the underlying mechanisms are not fully understood. Here, we developed a model of telomerase function imbalance using shRNA to knockdown TERC expression in human induced pluripotent stem cells (iPSCs). We then promoted in vitro hematopoiesis in these cells to analyze the effects of TERC impairment. Reduced TERC expression impaired hematopoietic stem-cell (HSC) differentiation and increased the expression of cellular senescence markers and production of reactive oxygen species. Interestingly, telomere length was unaffected in shTERC knockdown iPSCs, leading to conclusion that the phenotype is controlled by non-telomeric functions of telomerase. We then assessed the effects of TERC-depletion in THP-1 myeloid cells and again observed reduced hematopoietic and myelopoietic differentiative potential. However, these cells exhibited impaired telomerase activity as verified by accelerated telomere shortening. shTERC-depleted iPSC-derived and THP-1-derived myeloid precursors had lower phagocytic capacity and increased ROS production, indicative of senescence. These findings were confirmed using a BIBR1532 TERT inhibitor, suggesting that these phenotypes are dependent on telomerase function but not directly linked to telomere length. These data provide a better understanding of the molecular processes driving the clinical signs of telomeropathies and identify novel roles of the telomerase complex other than regulating telomere length. |
format | Online Article Text |
id | pubmed-6123533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61235332018-09-12 The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy Jose, Shyam Sushama Tidu, Federico Burilova, Petra Kepak, Tomas Bendickova, Kamila Fric, Jan Front Genet Genetics Telomeropathies are rare disorders associated with impaired telomere length control mechanisms that frequently result from genetic mutations in the telomerase complex. Dyskeratosis congenita is a congenital progressive telomeropathy in which mutation in the telomerase RNA component (TERC) impairs telomere maintenance leading to accelerated cellular senescence and clinical outcomes resembling premature aging. The most severe clinical feature is perturbed hematopoiesis and bone-marrow failure, but the underlying mechanisms are not fully understood. Here, we developed a model of telomerase function imbalance using shRNA to knockdown TERC expression in human induced pluripotent stem cells (iPSCs). We then promoted in vitro hematopoiesis in these cells to analyze the effects of TERC impairment. Reduced TERC expression impaired hematopoietic stem-cell (HSC) differentiation and increased the expression of cellular senescence markers and production of reactive oxygen species. Interestingly, telomere length was unaffected in shTERC knockdown iPSCs, leading to conclusion that the phenotype is controlled by non-telomeric functions of telomerase. We then assessed the effects of TERC-depletion in THP-1 myeloid cells and again observed reduced hematopoietic and myelopoietic differentiative potential. However, these cells exhibited impaired telomerase activity as verified by accelerated telomere shortening. shTERC-depleted iPSC-derived and THP-1-derived myeloid precursors had lower phagocytic capacity and increased ROS production, indicative of senescence. These findings were confirmed using a BIBR1532 TERT inhibitor, suggesting that these phenotypes are dependent on telomerase function but not directly linked to telomere length. These data provide a better understanding of the molecular processes driving the clinical signs of telomeropathies and identify novel roles of the telomerase complex other than regulating telomere length. Frontiers Media S.A. 2018-08-29 /pmc/articles/PMC6123533/ /pubmed/30210531 http://dx.doi.org/10.3389/fgene.2018.00345 Text en Copyright © 2018 Jose, Tidu, Burilova, Kepak, Bendickova and Fric. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Jose, Shyam Sushama Tidu, Federico Burilova, Petra Kepak, Tomas Bendickova, Kamila Fric, Jan The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy |
title | The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy |
title_full | The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy |
title_fullStr | The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy |
title_full_unstemmed | The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy |
title_short | The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy |
title_sort | telomerase complex directly controls hematopoietic stem cell differentiation and senescence in an induced pluripotent stem cell model of telomeropathy |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123533/ https://www.ncbi.nlm.nih.gov/pubmed/30210531 http://dx.doi.org/10.3389/fgene.2018.00345 |
work_keys_str_mv | AT joseshyamsushama thetelomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT tidufederico thetelomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT burilovapetra thetelomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT kepaktomas thetelomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT bendickovakamila thetelomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT fricjan thetelomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT joseshyamsushama telomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT tidufederico telomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT burilovapetra telomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT kepaktomas telomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT bendickovakamila telomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy AT fricjan telomerasecomplexdirectlycontrolshematopoieticstemcelldifferentiationandsenescenceinaninducedpluripotentstemcellmodeloftelomeropathy |